We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+13.4%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$1.67B
(+18%)
Cap. Flow
+$806M
Cap. Flow
% of AUM
7.42%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
678
New
211
Increased
171
Reduced
126
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ERF
Enerplus Corporation
ERF
|
+$91.2M |
| 2 |
TE Connectivity
TEL
|
+$81.6M |
| 3 |
Palo Alto Networks
PANW
|
+$78.9M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$75.6M |
| 5 |
Honeywell
HON
|
+$70.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$113M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
+$88.1M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$70.1M |
| 5 |
Synopsys
SNPS
|
+$64.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.5% |
| 2 | Technology | 22.75% |
| 3 | Industrials | 9.82% |
| 4 | Energy | 8.34% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Tenaya Therapeutics
TNYA
$160M
| $293K | ﹤0.01% |
+56,000
| New | +$268K |
|
502
JFrog
FROG
$10.1B
| $291K | ﹤0.01% |
6,576
+469
| +8% | +$18.2K |
|
|
CFLT
503
DELISTED
Confluent
CFLT
| $269K | ﹤0.01% |
+8,810
| New | +$249K |
|
504
Q32 Bio
QTTB
$482M
| $266K | ﹤0.01% |
+15,584
| New | +$215K |
|
505
N-able
NABL
$912M
| $257K | ﹤0.01% |
+19,671
| New | +$260K |
|
506
Sprinklr
CXM
$1.54B
| $257K | ﹤0.01% |
20,936
-1,205
| -5% | -$15.3K |
|
507
Celestica
CLS
$36.4B
| $251K | ﹤0.01% |
+5,586
| New | +$212K |
|
508
3D Systems Corp
DDD
$600M
| $248K | ﹤0.01% |
+55,888
| New | +$275K |
|
509
Ubiquiti
UI
$34.3B
| $228K | ﹤0.01% |
+1,966
| New | +$241K |
|
510
Alphabet (Google) Class A
GOOGL
$4.37T
| $225K | ﹤0.01% |
+1,490
| New | +$213K |
|
|
SEMR
511
DELISTED
Semrush
SEMR
| $224K | ﹤0.01% |
+16,905
| New | +$204K |
|
512
ManpowerGroup
MAN
$2.57B
| $218K | ﹤0.01% |
+2,812
| New | +$209K |
|
513
Gossamer Bio
GOSS
$86.9M
| $210K | ﹤0.01% |
+177,942
| New | +$196K |
|
514
Compugen
CGEN
$218M
| $208K | ﹤0.01% |
+80,556
| New | +$188K |
|
515
Karyopharm Therapeutics
KPTI
$44.9M
| $203K | ﹤0.01% |
8,941
+1,160
| +15% | +$20.3K |
|
516
Lexeo Therapeutics
LXEO
$364M
| $189K | ﹤0.01% |
+12,051
| New | +$188K |
|
|
OLO
517
DELISTED
Olo Inc
OLO
| $177K | ﹤0.01% |
32,190
+3,297
| +11% | +$18K |
|
|
CMRC
518
Commerce.com Inc Series 1
CMRC
$186M
| $174K | ﹤0.01% |
+25,299
| New | +$203K |
|
|
ALLK
519
DELISTED
Allakos
ALLK
| $147K | ﹤0.01% |
116,550
+44,994
| +63% | +$69.9K |
|
520
Enovix
ENVX
$942M
| $134K | ﹤0.01% |
+19,165
| New | +$166K |
|
|
VINC
521
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $120K | ﹤0.01% |
+1,182
| New | +$74.7K |
|
522
Conduent
CNDT
$270M
| $103K | ﹤0.01% |
+30,621
| New | +$106K |
|
523
Alignment Healthcare
ALHC
$2.83B
| $92.8K | ﹤0.01% |
+18,700
| New | +$120K |
|
524
Capricor Therapeutics
CAPR
$241M
| $84.6K | ﹤0.01% |
12,461
-897,081
| -99% | -$4.34M |
|
525
Asure Software
ASUR
$249M
| $81.4K | ﹤0.01% |
+10,458
| New | +$93.8K |
|
Similar funds
TCIIS
UIM
VAI
KK
Woodline Partners's Q1 2024 Portfolio in Review
As of Q1 2024, Woodline Partners held 678 positions worth $10.9B, up 18% from $9.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Woodline Partners deployed $806M of net new capital in Q1 2024, opening 211 new positions and adding to 171 existing holdings. Its largest new stake was Enerplus Corporation: 5,602,613 shares worth $110M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $110M trimmed.
- Woodline Partners's largest Q1 2024 buy was Enerplus Corporation: 5,602,613 shares worth $110M.
- Woodline Partners added most to TE Connectivity in Q1 2024, an estimated $81.6M increase.
- Woodline Partners's biggest Q1 2024 reduction was AbbVie, cutting an estimated $110M.
- Woodline Partners fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $113M.
- Woodline Partners's ten largest holdings make up 14% of its $10.9B portfolio in Q1 2024.
- Woodline Partners opened 211 new positions and closed 150 in Q1 2024.
- Woodline Partners's portfolio value rose 18% quarter-over-quarter to $10.9B.
Based on Woodline Partners's 13F filing for Q1 2024, filed 15 May 2024.